Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phospholipid ether analogs as cancer-targeting drug vehicles

Phospholipid ether analogs as cancer-targeting drug vehicles

US Patent 9345718 · Granted May 24, 2016

Estimated economic value: $1,057,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phospholipid ether analogs for imaging and targeted treatment of pediatric solid2025
PSMA-targeting ligands with optimal properties for imaging and therapy2025
PSMA-targeting ligands with optimal properties for imaging and therapy2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Cationic cyclic amine and amphipathic transfection reagents2023
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination2023
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination2023
Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunot2023
Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunot2023
Long-lived gadolinium based tumor targeted imaging and therapy agents2023
Long-lived gadolinium based tumor targeted imaging and therapy agents2023